CDNA
CareDx, Inc.
Key Financials
Net Income
$-21354000
↓ 140.6%
Gross Profit
$81.6M
↑ 87.3%
Revenue
$379.8M
↑ 13.8%
EPS (Diluted)
$-0.40
↓ 143.0%
Operating Income
$-30781000
↓ 175.5%
Total Assets
$413.2M
↓ 15.8%
Total Liabilities
$110.1M
↓ 2.2%
Shareholders' Equity
$303.1M
↓ 19.9%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 8-K/A | 9/16/2026 | View on SEC |
| 4 | 9/15/2026 | View on SEC |
| 4 | 9/15/2026 | View on SEC |
| 144 | 8/17/2026 | View on SEC |
| 144 | 8/14/2026 | View on SEC |
| SCHEDULE 13G/A | 8/14/2026 | View on SEC |
| 144 | 8/13/2026 | View on SEC |
| 144 | 8/12/2026 | View on SEC |
| 144 | 8/11/2026 | View on SEC |
| 144 | 8/10/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | CDNA |
| Company Name | CareDx, Inc. |
| CIK | 1217234 |
| Sector | Services-Medical Laboratories |
| Industry | Large accelerated filer |
| Exchange | Nasdaq |
| SIC Code | 8071 |
| SIC Description | Services-Medical Laboratories |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 415-287-2300 |